MHLW Official Expounds on “Authorized Biosimilar” Pricing, 50% Generic Rule Applies for “Biosame” Products

Biosimilar Forum in Tokyo If a follow-on biologic is manufactured under the exact same conditions as those for its originator, this “biosame” product will be handled as a “generic” under the current pricing rules in Japan, receiving an NHI price...read more